Kanabo Group PLC

KNB

Company Profile

  • Business description

    Kanabo Group PLC is a digital health company committed to transforming patient care through its technology platform and specialized treatment offerings. It is focused on researching, developing, and commercializing regulated medicinal cannabis-derived formulations and therapeutic inhalation devices. Its NHS-approved online telehealth platform, The GP Service, which provides patients with video consultations, online prescriptions, and primary care services. Its segments include Primary Care, which includes telepharma services provided by GPS, and Secondary Care, which includes the development and distribution of cannabis derived medicinal and wellness products. It derives the majority of revenue from Primary Care. Geographically, it operates in the United Kingdom and Israel.

  • Contact

    137-139 Brent Street
    Churchill House
    LondonNW4 4DJ
    GBR

    T: +44 2074690930

    E: [email protected]

    http://www.kanabogroup.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Care Facilities

    Fiscal Year End

    31 December 2026

    Employees

    16

Stocks News & Analysis

stocks

The strange effect of the 30% minimum capital gains tax

How the proposed CGT floor creates unexpected outcomes across different incomes.
stocks

ASX restaurant chain remains cheap

Is the market overlooking this undervalued fast food chain?
stocks

Major ASX miner reduces aluminium exposure

The Alcoa transaction unlocks value and sharpens ASX miners focus on base metals.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,000.5043.00-0.48%
CAC 408,479.8728.20-0.33%
DAX 4025,817.8938.580.15%
Dow JONES (US)53,055.91155.840.29%
FTSE 10010,651.7727.26-0.26%
HKSE23,517.7098.62-0.42%
NASDAQ26,121.16288.491.12%
Nikkei 22568,540.781,196.91-1.72%
NZX 50 Index13,769.556.450.05%
S&P 5007,537.4354.190.72%
S&P/ASX 2008,797.1042.30-0.48%
SSE Composite Index3,999.0342.21-1.04%

Market Movers